JPRN-jRCT2031220072招募中2 期
A Phase II, placebo-controlled, randomized, double-blind, parallel-group, multicenter study to evaluate efficacy and safety of M605110 in patients with axillary osmidrosis
Tomoyuki Nishiura0 个研究点目标入组 105 人开始时间: 2022年5月19日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 105
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 15age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Patients with axillary osmidrosis 15 years old and over
排除标准
- •(1)Not suitable for application of investigational drug from the viewpoint of safety, such as a wound on the axilla, or patients with complications or abnormal findings on the axilla affecting safety assessment.
- •(2)Patients judged by the investigator or sub-investigator to have a degree of odor(other than axillary odor) that may affect the evaluation of axillary odor.
研究者
相似试验
招募中
2 期
A Phase II study of M528101 for postherpetic neuralgiaJPRN-jRCT2031220415Tomoyuki Nishiura18
招募中
2 期
A study in people with systemic sclerosis to test whether BI 685509 has an effect on lung function and other systemic sclerosis symptomsEarly progressive diffuse cutaneous systemic sclerosisJPRN-jRCT2041220079Ogawa Shintaro200
招募中
2 期
A Trial to Compare BI drug with Placebo for Patients With SclerodermaCTRI/2023/07/054769Boehringer Ingelheim
招募中
1 期
A study in people with systemic sclerosis to test whether BI 685509 has an effect on lung function and other systemic sclerosis symptomssystemic sclerosisCTIS2022-500332-11-00Boehringer Ingelheim International GmbH200
进行中（未招募）
1 期
Phase II vaccination trial in HIV-1 infected subjectsChronic HIV-1 infectionMedDRA version: 19.0Level: LLTClassification code 10068341Term: HIV-1 infectionSystem Organ Class: 100000004862EUCTR2016-002724-83-BEErasmus MC70